Patent · US Active

Composition for the treatment of atherosclerosis

US8324152B2 · kind B2 · utility

2Cited by

3References

7Claims

0Family size

Assignee

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Alain Tedgui · Paris, FR
Ziad Mallat · Paris, FR

Key dates

Filing date	Jan 4, 2006
Grant date	Dec 4, 2012
Priority date	—
Expiry date	Sep 27, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention concern a composition or a patch adapted for the prophylactic or therapeutic treatment by continuous subcutaneous administration of a subject suffering from atherosclerosis, comprising an effective amount of at least one epitope derived from a protein present in the atherosclerotic plaque, whereby administration of said at least one epitope to said subject induces a specific regulatory immune response, preferably a Treg response.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.